Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Go back to Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 6.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.00 | 52 Week High | $18.00 | |||
| Open | $6.00 | 52 Week Low | $6.91 | |||
| Day High | $6.00 | P/E | N/A | |||
| Day Low | $6.00 | EPS | $-0.67 | |||
| Volume | 2,014 | |||||
